ArticleJournal of thoracic disease2025
Comparison of uniportal and three-portal video-assisted thoracoscopic thymectomy for thymoma: a propensity score-matched study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Minimally invasive thymectomy (MIT) is a surgical approach to thymectomy. To investigate the efficacy of the MIT, a retrospective comparison for perioperative outcomes of patients was conducted between uniportal and three-portal video-assisted thoracoscopic surgery (UP-VATS and TP-VATS) thymectomy. Methods: A detailed database search identified 135 patients treated with UP-VATS thymectomy technique and 228 patients treated via TP-VATS thymectomy technique between January 2013 and December 2022 from the same surgeon and medical team. Propensity score-matched analysis was used to compare the perioperative outcomes between the two groups. Results: The first 20 patients were excluded to account for the learning curve effect in both groups. There were 115 patients screened in each group after propensity match. There was 14.8% morbidity in the UP-VATS group and 12.2% morbidity in the TP-VATS group, with no significant differences between the two groups. Furthermore, no significant differences in other perioperative outcomes were found between the two groups. Although the volume of drainage (86.2 Conclusions: Thymectomy treatment of TP-VATS is an advisable procedure for patients with thymoma, while these two MIT techniques are both appropriate for thymoma treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.